Peer Review History

Original SubmissionMay 14, 2024
Decision Letter - Tien Anh Tran, Editor

PONE-D-24-18964Lead acetate–based test strip method for rapid and quantitative detection of residual sulfur dioxide in Chinese herbal medicinesPLOS ONE

Dear Dr. Zhao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thank you so much for your submission. Kindly prepare your revised paper through addressing all comments of the reviewers. I am looking forwarding to receiving your revised paper to re-evaluate for Plos One. ==============================

Please submit your revised manuscript by Aug 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tien Anh Tran

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ".

3. Thank you for stating the following financial disclosure: 

 [This work was supported by the Key R&D plan of Shaanxi Province (No.2021ZDLSF01-07), Shaanxi provincial People's Hospital Science and Technology Personnel Support Program(No.2021LJ-02), Key Research and development program of Shaanxi Province(No.2022KWZ-20), Shaanxi provincial People's Hospital Science and Technology Development Incubation Fund(2023YJ-22)Key Research and development program of Shaanxi Province(2024SF-YBXM-081)].  

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

"""

5. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. 

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

6. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"" files".

Additional Editor Comments:

Thank you so much for your submission. After considering carefully the comments of the experts. Your paper must be improved and revised all comments of the experts. We are looking forward to receiving your revised manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: N/A

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this work, the authors introduce lead acetate–based test strip method for rapid and quantitative detection of residual sulfur dioxide in Chinese herbal medicines. The content is detailed and enriching, showcasing the authors' broad perspective. However, there are several issues within the article that require some modifications:

1. Please reorganize the abstract part. Background, Methods, Results and Conclusions should not be indicated.

2. Please rewrite the keyword ‘Quantitative’.

3. The section 2. Materials and methods need to be reorganized. There are too many subtitles which make experimental details unclear.

4. Please reorganize the results part by reducing subtitles and extract the main results followed by significant biological explication.

5. Please add scale in Figure 1.

6. Please add error bar in the experimental curves.

7. The figutes are not good presented.

8. The table 2 is not good enough.

In conclusion, the author shows enough expermental details and results to support the main idea. However, the work needs to be slightly improved. I recommend the publication after a major revision.

Reviewer #2: In section 3.2. Preparation of standard grayscale cards, teststrips with a lead acetate concentration of 15% were prepared. However, in section 3.1.2.1. and Figure 2a, lead acetate with concentration of 20% showed better linear pattern of the detected gray value.

In section 3.4.2.1. Precision testing, SO2 residual concentration for the three herbs was not clearly addressed in the method part.

The colors of the line on Figure 2a can’t correspond to the caption beside it.

Reviewer #3: In this manuscript, entitled “Lead acetate–based test strip method for rapid and quantitative detection of residual sulfur dioxide in Chinese herbal medicines”, the authors developed a rapid and quantitative sulfur dioxide detection technique for the evaluation of sulfur dioxide residues in Chinese herbal medicines. The authors converted the sulfur dioxide to hydrogen sulfide, which was then detected using lead acetate test paper. My questions and suggestions are as follows:

1. In “Introduction” section:

Why don't you refer to the latest edition of Chinese Pharmacopoeia (2020)?

In addition to the mentioned common detection methods in addition to acid-base titration, ion chromatography, gas chromatography, fluorescence derivatization, colorimetry, etc., there are also many methods for the rapid detection of sulfur dioxide residue in Chinese herbal medicine. Please provide an overview of the latest research to highlight the need for the detection methods in this study.

2. In “Methods” section:

Please attach the chemical reaction formula.

What was the reason for choosing sodium borohydride (NaBH₄) as the reducing agent? The reaction between sulfur dioxide or sulfite and sodium borohydride is not a common chemical reaction because their chemical properties do not directly promote such reactions under normal conditions. However, under certain conditions, the two compounds may react, but this is rare and the reaction conditions are usually harsh. What reaction conditions were used in this study to facilitate the reaction? This point is not seen in the article at present!

Why not use real Chinese medicine for research? In this study, what is the role of Chinese herbal medicine extract in it? Is it just a simulation? The real detection method will carry out pre-extraction treatment of Chinese medicinal materials, and the pre-treatment steps will also affect the reaction conditions. Therefore, the use of Chinese medicinal materials for real detection is an essential part of the establishment of the new methodology!

It is suggested that a batch of Chinese medicinal materials should be simultaneously tested by other known mature methods, such as acid-base titration in Chinese Pharmacopoeia, in order to demonstrate the accuracy of the detection results of this method.

3. In “3.1.1”:

In this part, the best reaction time was determined to be 10 min. Why was 15 min used in 3.1.2.1. to detect the influence of different concentrations of lead acetate on the detection accuracy?

4. In “3.1.2.1”:

In this part, CN95 membrane was used to detect the influence of different concentrations of lead acetate on the detection accuracy. However, the best experimental membrane type was determined as CN 140 in 3.1.2.2. Please explain the different membrane types of the two parts!

Should the optimal membrane type be determined first, and then the influence of the concentration of lead acetate under the optimal membrane type on the detection results be tested?

5. In “Discussion” section:

There is no discussion section in this paper. Please supplement the latest progress of relevant technology in the current research field, compare it with this study, and discuss the limitations and future research direction of this technology!

Reviewer #4: The paper has established a rapid detection technique utilizing lead acetate test strips for the prompt identification of SO2 in traditional Chinese medicinal materials and herbal preparations. The idea is interesting and data is fine. I Just have two questions.

1. Why the membrane type has effect on detection accuracy? The authors should address it in the context.

2. The language need to be improved and polished.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: HSU, SHUO-MIN

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

I ensure that my manuscript meets PLOS ONE's style requirements, including those for file naming.

I ensure that I have an ORCID iD and that it is validated in Editorial Manager.

All of the authors approved the submitted version (and any substantially modified version that involves the author’s contribution to the study) and All of the authors agrees to be personally accountable for the author’s contributions AND to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated, resolved, and the resolution documented in the literature

This work was supported by the Key Research and development program of Shaanxi Province(2024SF-YBXM-081), Shaanxi provincial People's Hospital Science and Technology Personnel Support Program(No.2021LJ-02), Key Research and development program of Shaanxi Province(No.2022KWZ-20), Shaanxi provincial People's Hospital Science and Technology Development Incubation Fund(2023YJ-22)Shaanxi Provincial health and Medical Research Innovation Capacity Enhancement Plan(2024PT-01), Shaanxi Province Innovation Capability Support Program Project (S2024-ZC-TD-0127), Shaanxi Provincial health high-level talent cultivation program, the Shaanxi Special Support Plan for High Level Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

We did not multiple submissions for one draft, this is our original article. We corrected all the comments above point to point. See the corrected article for details

The Figure 1 in our submission contain copyrighted images. Thank you for your insightful comments. We appreciate your guidance and understand the importance of adhering to the CC BY4.0 license requirements. The figure in this paper is similar but not identical to the original image for illustrative purposes only, we have clearly indicated this in the figure caption, including the source information as required.

We assure you that we will address these matters with the utmost diligence and professionalism. Thank you for your understanding and support throughout the peer-review process.

We revised on the reviewer's suggestion regarding the inclusion of tables within the main text of our manuscript and the retention of supplementary tables as separate "supporting information" files.

Attachments
Attachment
Submitted filename: 1. Response to Reviewers.docx
Decision Letter - Tien Anh Tran, Editor

Lead acetate–based test strip method for rapid and quantitative detection of residual sulfur dioxide in Chinese herbal medicines

PONE-D-24-18964R1

Dear Dr. Zhao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tien Anh Tran

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

After reviewing carefully your revised paper and the recommendations of reviewers, the current manuscript could be accepted to publish on Plos One.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #4: As for the revision, I think all my questions are answered and I think the manuscript is acceptable now.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #4: No

**********

Formally Accepted
Acceptance Letter - Tien Anh Tran, Editor

PONE-D-24-18964R1

PLOS ONE

Dear Dr. Zhao,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Tien Anh Tran

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .